Inorganic Nanomaterials for the Development of Drug Delivery and Biomedical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 4959
Special Issue Editor
Interests: cancer theranostics; inorganic nanomaterials; drug delivery
Special Issue Information
Dear Colleagues,
Various types of inorganic nanomaterials, such as upconverting nanoparticles, quantum dots, magnetic nanoparticles, mesoporous silica nanoparticles, graphene oxide, gold nanoparticles, carbon nanotubes and layered double hydroxide nanoparticles, have been widely studied as therapeutic drugs and delivery carriers in the biomedical field. Their controllable physicochemical characteristics, unique optical/electrical/magnetic/catalytic properties and good biocompatibility mean inorganic nanoparticles have great potential to improve humans’ medical conditions and aid in the early detection, diagnosis, treatment and follow-up of various diseases. For example, iron oxide nanoparticles and gold nanoparticles are approved for clinical application, and other kinds of inorganic nanoparticles are currently undergoing clinical trials.
However, a complete revolution in inorganic nanomedicine for drug delivery and biomedical applications is still a long way away. This Special Issue will focus on “Inorganic Nanomaterials for the Development of Drug Delivery and Biomedical Applications” and is an open forum where researchers can share their investigations and findings in this promising field. Contributions to this collection, both in the form of original research and review articles, may cover all aspects of the biomedical applications of inorganic nanoparticles; studies with multidisciplinary input offering new methodologies or insights are particularly welcome.
Dr. Jianping Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inorganic nanoparticles
- drug delivery
- disease diagnosis
- disease treatment
- nano-biosensor
- cancer theranostics
- cancer imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
